BIOMAT Database Logo BIOMAT Database Logo

Adjuvant therapy in postmenopausal node-positive breast cancer. 1985

A Goldhirsch, and R D Gelber, and F Cavalli, and C M Rudenstam, and M N Tattersall

UI MeSH Term Description Entries
D008207 Lymphatic Metastasis Transfer of a neoplasm from its primary site to lymph nodes or to distant parts of the body by way of the lymphatic system. Lymph Node Metastasis,Lymph Node Metastases,Lymphatic Metastases,Metastasis, Lymph Node
D008593 Menopause The last menstrual period. Permanent cessation of menses (MENSTRUATION) is usually defined after 6 to 12 months of AMENORRHEA in a woman over 45 years of age. In the United States, menopause generally occurs in women between 48 and 55 years of age. Change of Life, Female
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

A Goldhirsch, and R D Gelber, and F Cavalli, and C M Rudenstam, and M N Tattersall
Epirubicin for adjuvant therapy in node-positive breast cancer.
February 2000, The Medical letter on drugs and therapeutics,
A Goldhirsch, and R D Gelber, and F Cavalli, and C M Rudenstam, and M N Tattersall
Adjuvant treatment in node-negative, postmenopausal breast cancer.
January 2001, Cancer investigation,
A Goldhirsch, and R D Gelber, and F Cavalli, and C M Rudenstam, and M N Tattersall
Hormonal versus chemohormonal adjuvant therapy in node-positive postmenopausal patients.
November 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
A Goldhirsch, and R D Gelber, and F Cavalli, and C M Rudenstam, and M N Tattersall
Adjuvant therapy for patients who have node-positive breast cancer.
January 2006, Advances in surgery,
A Goldhirsch, and R D Gelber, and F Cavalli, and C M Rudenstam, and M N Tattersall
Adjuvant Systemic Therapy for Postmenopausal, Hormone Receptor-Positive Early Breast Cancer.
February 2023, Hematology/oncology clinics of North America,
A Goldhirsch, and R D Gelber, and F Cavalli, and C M Rudenstam, and M N Tattersall
Adjuvant therapy in node-positive vulvar cancer.
July 2013, Expert review of anticancer therapy,
A Goldhirsch, and R D Gelber, and F Cavalli, and C M Rudenstam, and M N Tattersall
Adjuvant docetaxel for node-positive breast cancer.
September 2005, The New England journal of medicine,
A Goldhirsch, and R D Gelber, and F Cavalli, and C M Rudenstam, and M N Tattersall
Adjuvant docetaxel for node-positive breast cancer.
September 2005, The New England journal of medicine,
A Goldhirsch, and R D Gelber, and F Cavalli, and C M Rudenstam, and M N Tattersall
Adjuvant docetaxel for node-positive breast cancer.
June 2005, The New England journal of medicine,
A Goldhirsch, and R D Gelber, and F Cavalli, and C M Rudenstam, and M N Tattersall
Regarding the dilemma of adjuvant therapy in postmenopausal patients with node-positive, estrogen receptor-positive breast cancer: are we better informed?
April 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
Copied contents to your clipboard!